Rachel Etherington
Oxford Biotherapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Liver Diseases and Immunity, COVID-19 Clinical Research Studies, Dermatology and Skin Diseases, Pediatric Hepatobiliary Diseases and Treatments, Immune responses and vaccinations
Most-Cited Works
- → A blood atlas of COVID-19 defines hallmarks of disease severity and specificity(2022)323 cited
- → Novel bile acid therapeutics for the treatment of chronic liver diseases(2016)46 cited
- → Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19(2022)35 cited
- → Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs(2023)30 cited
- → Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury(2022)30 cited
- → Squamous carcinoma in the liver.(1990)23 cited
- → Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation(2019)19 cited
- → Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis(2021)14 cited
- → Demonstration of T-Cell Monotypia Using Anti-TCRbeta1/2 (TRBC1/2) Immunostaining as a Rapid and Cost-Effective Alternative to PCR-Based Clonality Studies for the Diagnosis of T-Cell Lymphoma(2024)6 cited